Consensus HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Market Closed - Swiss Exchange Other stock markets 11:30:41 2023-12-08 am EST			5-day change	1st Jan Change
170 ^CHF	-2.30%		-2.86%	-15.42%

Dec. 01	AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	MT
Nov. 21	Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	MT

Evolution of the average Target Price on HBM Healthcare Investments AG

Price target over the last 5 years

History : Analyst Recommendations

e0a3bdf6b5baac.7b_FBOCWjUBtCBGS0ZVWHa-FMlzuDlcu5GZ3A6Ow0Uw.udnzZtbRvRIiQ0HQndMuS_ewUwmITwB9iFYTTerFmQWii69q1PHSIy9tYg~1e092ab1d50e2bd6bbe2bce040043805

Analyst Recommendations on HBM Healthcare Investments AG

Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	Nov. 21	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	Jun. 14	MT